{
 "as_of": "2026-11-06",
 "cmr": "uk-cm-kg/LSE/GENF",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# GENFLOW BIOSCIENCES PLC (LSE Main Market: GENF) — research page\n\nAs of 2026-11-06 · uk-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is GENFLOW BIOSCIENCES PLC, listed on the LSE Main Market under ticker GENF, ISIN GB00BP2C3V08, LEI 213800HVOFXRXVEGDN62. Its security type is Corporate, its segment is SSQ3, its sector is Pharmaceuticals and Biotechnology [201030], and its jurisdiction is England and Wales (Companies House jurisdiction field). Its listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 43 filings across 39 filing days in the window 2025-11-06 to 2026-11-06. The median gap between filing days is 7.0 days, against a median of 4 days for the LSE Main Market (892 issuers) and 6.0 days for the sector (51 issuers). Days from the latest filing to the record date are 7, against a median latency of 3 days for the exchange and 4.0 days for the sector. The latest filing is dated 2026-10-30 and is of type corporate_action.\n\n## Auditor\n\nThe auditor of record is PKF Littlejohn LLP. Its location is not on the record. Auditor changes are not on the record.\n\n## Events and halts\n\nListing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. The halt flag shows listed, not halted.\n\n## Orderability\n\nFor the elective professional client category, the signal is ACM-200 and the outcome is determinable. For the eligible counterparty category, the signal is ACM-200 and the outcome is determinable. The rule version is acm-68000/uk/product-governance-fca-prod-sourcebook/r1, with the chapter as of 2026-11-04.\n\n## Coverage\n\nNo research houses were found on the issuer's investor-relations pages read. The count is 0.\n\n## Open research\n\nNo openly published research notes were found. The count is 0.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe market's vintage is not sealed. No issuer years are sealed. The live record began on 2026-09-11. Years 2021 to 2026 are sealed in the store but are not served as of a date, and the as-of door answers not_sealed.\n\n## Sources\n\n10 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (identity.exchange)\n- https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/GENF (identity.isin)\n- https://find-and-update.company-information.service.gov.uk/company/13138531 (identity.jurisdiction)\n- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)\n- https://www.londonstockexchange.com/stock/GENF/genflow-biosciences-plc/company-page (identity.sector)\n- https://mcp.uk-cm-kg.ai/events/LSE/GENF (the disclosure lines)\n- https://marketsecurities.fca.org.uk/officiallist (the halt flag)\n- https://genflowbio.com/wp-content/uploads/2023/04/Genflow-Accounts-31-December-2022-v4-FINAL2.pdf (the auditor)\n- https://mcp.uk-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://mcp.uk-cm-kg.ai/record/LSE/GENF (the record)\n",
 "market": "UK",
 "node": "uk-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": "2026-09-11",
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "6 years are sealed in the UK store; their Replay split is not built, so the as-of door answers not_sealed and the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false,
   "store_years_sealed_not_served": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ]
  },
  "auditor": {
   "auditor": {
    "read_by": "Tavily regex",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://genflowbio.com/wp-content/uploads/2023/04/Genflow-Accounts-31-December-2022-v4-FINAL2.pdf",
    "state": "confirmed",
    "value": "PKF Littlejohn LLP"
   },
   "auditor_firm_id": {
    "market": "UK",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "UK",
    "state": "not_on_record"
   },
   "changes": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "cmr": "uk-cm-kg/LSE/GENF",
  "coverage": {
   "count": 0,
   "houses": [],
   "pages_checked": [],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": null,
   "state": "none_found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 892,
     "median_cadence_gap_days": 4,
     "median_filings": 29,
     "median_latency_days": 3,
     "name": "LSE Main Market"
    },
    "sector": {
     "issuers": 51,
     "median_cadence_gap_days": 6,
     "median_filings": 42,
     "median_latency_days": 4,
     "name": "Pharmaceuticals and Biotechnology [201030]"
    }
   },
   "by_type": {
    "agm_record_date": 3,
    "ch_accounts_filed": 1,
    "ch_capital": 3,
    "ch_confirmation_statement": 1,
    "ch_officer_change": 2,
    "ch_other": 1,
    "ch_resolution": 3,
    "corporate_action": 3,
    "director_dealing": 2,
    "early_warning": 1,
    "financial_statement": 3,
    "newswire_release": 3,
    "regulatory_announcement": 17
   },
   "cadence_median_gap_days": 7,
   "filing_days": 39,
   "filings": 43,
   "latency_days": 7,
   "latest": [
    {
     "category": null,
     "date": "2026-10-30",
     "source": "https://www.investegate.co.uk/announcement/rns/genflow-biosciences--genf/total-voting-rights/9849141",
     "title": "Total Voting Rights",
     "type": "corporate_action"
    },
    {
     "category": null,
     "date": "2026-10-09",
     "source": "https://www.investegate.co.uk/announcement/rns/genflow-biosciences--genf/corporate-update-/9816283",
     "title": "Corporate Update",
     "type": "regulatory_announcement"
    },
    {
     "category": null,
     "date": "2026-10-07",
     "source": "https://find-and-update.company-information.service.gov.uk/company/13138531/filing-history/MzU0OTcyNDA5MGFkaXF6a2N4/document?format=pdf&download=0",
     "title": "capital allotment shares — 2026-10-02",
     "type": "ch_capital"
    },
    {
     "category": null,
     "date": "2026-10-05",
     "source": "https://www.investegate.co.uk/announcement/rns/genflow-biosciences--genf/presentation-of-interim-results-/9805359",
     "title": "Presentation of Interim Results",
     "type": "financial_statement"
    },
    {
     "category": null,
     "date": "2026-09-10",
     "source": "https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-tyra-biosciences-inc---tyra-302875825.html",
     "title": "INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tyra Biosciences, Inc. - TYRA - PR Newswire",
     "type": "newswire_release"
    }
   ],
   "latest_filing_date": "2026-10-30",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.uk-cm-kg.ai/events/LSE/GENF",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "LSE price explorer (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=MAINMARKET, categories=EQUITY, showonlylse=true)",
    "state": "sourced",
    "value": "LSE Main Market"
   },
   "isin": {
    "read_by": "LSE instrument reference record (exchange site)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/GENF",
    "state": "confirmed",
    "value": "GB00BP2C3V08"
   },
   "jurisdiction": {
    "read_by": "Companies House REST API (company profile) (jurisdiction field)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://find-and-update.company-information.service.gov.uk/company/13138531",
    "state": "confirmed",
    "value": "England and Wales (Companies House jurisdiction field)"
   },
   "lei": {
    "read_by": "GLEIF ISIN-to-LEI mapping file (daily), LEI by exact ISIN",
    "read_date": "2026-11-09",
    "read_date_basis": "the field",
    "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download (ISIN GB00BP2C3V08)",
    "state": "sourced",
    "value": "213800HVOFXRXVEGDN62"
   },
   "name": {
    "read_by": "LSE price explorer (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=MAINMARKET, categories=EQUITY, showonlylse=true)",
    "state": "sourced",
    "value": "GENFLOW BIOSCIENCES PLC"
   },
   "sector": {
    "read_by": "LSE issuer profile (exchange site)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/stock/GENF/genflow-biosciences-plc/company-page",
    "state": "sourced",
    "value": "Pharmaceuticals and Biotechnology [201030]"
   },
   "security_type": {
    "read_by": "LSE price explorer (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=MAINMARKET, categories=EQUITY, showonlylse=true)",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "read_by": "LSE price explorer (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=MAINMARKET, categories=EQUITY, showonlylse=true)",
    "state": "sourced",
    "value": "SSQ3"
   },
   "ticker": {
    "read_by": "LSE price explorer (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=MAINMARKET, categories=EQUITY, showonlylse=true)",
    "state": "sourced",
    "value": "GENF"
   },
   "website": {
    "market": "UK",
    "reason": "no source read",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "domicile_change": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "listing": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "name_change": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "segment_move": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "market": "UK",
  "node": "uk-cm-kg",
  "numbers_hash": "sha256:a7f62d4527932db3d453cb456ce30ce6640a4b3d8b4b8698f6b99e2284e235e5",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [
    "elective professional client",
    "eligible counterparty"
   ],
   "outcomes": {
    "elective professional client": {
     "determinable": true,
     "signal": "ACM-200"
    },
    "eligible counterparty": {
     "determinable": true,
     "signal": "ACM-200"
    }
   },
   "read": {
    "basis": "one live read per instrument class, halt state and client category on this market; this issuer's group",
    "chapter": "https://mcp.uk-cm-kg.ai/book/aio.json",
    "door": "https://mcp.uk-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "rule_version": "acm-68000/uk/product-governance-fca-prod-sourcebook/r1",
   "section": "uk.aio.v16"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.uk-cm-kg.ai/record/LSE/GENF",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-09",
   "source": "https://marketsecurities.fca.org.uk/officiallist",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:a7f62d4527932db3d453cb456ce30ce6640a4b3d8b4b8698f6b99e2284e235e5",
 "path": "/uk/LSE/GENF",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is GENFLOW BIOSCIENCES PLC, listed on the LSE Main Market under ticker GENF, ISIN GB00BP2C3V08, LEI 213800HVOFXRXVEGDN62. Its security type is Corporate, its segment is SSQ3, its sector is Pharmaceuticals and Biotechnology [201030], and its jurisdiction is England and Wales (Companies House jurisdiction field). Its listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 43 filings across 39 filing days in the window 2025-11-06 to 2026-11-06. The median gap between filing days is 7.0 days, against a median of 4 days for the LSE Main Market (892 issuers) and 6.0 days for the sector (51 issuers). Days from the latest filing to the record date are 7, against a median latency of 3 days for the exchange and 4.0 days for the sector. The latest filing is dated 2026-10-30 and is of type corporate_action.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is PKF Littlejohn LLP. Its location is not on the record. Auditor changes are not on the record.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "Listing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. The halt flag shows listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "For the elective professional client category, the signal is ACM-200 and the outcome is determinable. For the eligible counterparty category, the signal is ACM-200 and the outcome is determinable. The rule version is acm-68000/uk/product-governance-fca-prod-sourcebook/r1, with the chapter as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "No research houses were found on the issuer's investor-relations pages read. The count is 0.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found. The count is 0.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The market's vintage is not sealed. No issuer years are sealed. The live record began on 2026-09-11. Years 2021 to 2026 are sealed in the store but are not served as of a date, and the as-of door answers not_sealed.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "10 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer"
  },
  {
   "for": "identity.isin",
   "source": "https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/GENF"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://find-and-update.company-information.service.gov.uk/company/13138531"
  },
  {
   "for": "identity.lei",
   "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download"
  },
  {
   "for": "identity.sector",
   "source": "https://www.londonstockexchange.com/stock/GENF/genflow-biosciences-plc/company-page"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.uk-cm-kg.ai/events/LSE/GENF"
  },
  {
   "for": "the halt flag",
   "source": "https://marketsecurities.fca.org.uk/officiallist"
  },
  {
   "for": "the auditor",
   "source": "https://genflowbio.com/wp-content/uploads/2023/04/Genflow-Accounts-31-December-2022-v4-FINAL2.pdf"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.uk-cm-kg.ai/book/aio.json"
  },
  {
   "for": "the record",
   "source": "https://mcp.uk-cm-kg.ai/record/LSE/GENF"
  }
 ],
 "title": "GENFLOW BIOSCIENCES PLC (GENF) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}